Immunomodulation as innovative therapy for head and neck tumors. Current developments

被引：1
|
作者：
Schuler, P. J. [1 ]
Doescher, J. C. [1 ]
Laban, S. [1 ]
Hoffmann, T. K. [1 ]
机构：
[1] Univ Ulm Klinikum, Univ Klin Hals Nasen Ohrenheilkunde Kopf & Halsch, Frauensteige 12, D-89075 Ulm, Germany
来源：
HNO | 2016年 / 64卷 / 07期
关键词：
Head and neck neoplasms; Immunotherapy; Monoclonal antibodies; Programmed cell death 1 receptor; Vaccination; SQUAMOUS-CELL CARCINOMA; RECEPTOR FUSION PROTEIN; PHASE-I TRIAL; OPEN-LABEL; CANCER; RECURRENT; IMMUNOTHERAPY; DALANTERCEPT; COMBINATION; VACCINATION;
D O I：
10.1007/s00106-016-0131-0
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Head and neck squamous cell carcinoma (HNSCC) is characterized by its intense immune suppression and its elaborate immune escape mechanisms. Due to the fact that survival rates remain low, the role of immunotherapy has become more important and the focus of current clinical studies has shifted toward antibody-based immune checkpoint modulation. Application of immunotherapy in curative settings or for prevention of recurrent disease would be desirable.
引用
收藏
页码：470 / 478
页数：9
相关论文
共 50 条
  • [1] Translational Insights and New Therapeutic Perspectives in Head and Neck Tumors
    Fasano, Morena
    Perri, Francesco
    Della Corte, Carminia Maria
    Di Liello, Raimondo
    Scarpati, Giuseppina Della Vittoria
    Cascella, Marco
    Ottaiano, Alessandro
    Ciardiello, Fortunato
    Solla, Raffaele
    BIOMEDICINES, 2021, 9 (08)
  • [2] Immunotherapy of head and neck cancer. Current developments
    Schuler, P. J.
    Hoffmann, T. K.
    Gauler, T. C.
    Bergmann, C.
    Brandau, S.
    Lang, S.
    HNO, 2013, 61 (07) : 559 - 572
  • [3] Immunotherapy of head and neck tumors. Highlights of the ASCO Meeting 2015
    Laban, S.
    Doescher, J.
    Schuler, P. J.
    Bullinger, L.
    Brunner, C.
    Veit, J. A.
    Hoffmann, T. K.
    HNO, 2015, 63 (09) : 612 - 619
  • [4] Immuno-oncology of head and neck tumors
    Kasper, Stefan
    Hussain, Timon
    Virchow, Isabel
    Stuschke, Martin
    Lang, Stephan
    HNO, 2019, 67 (03) : 221 - 235
  • [5] Pathology of malignant head and neck tumors. Epidemiology and histological subtypes
    Stenzinger, A.
    Kriegsmann, M.
    Kraywinkel, K.
    Weichert, W.
    ONKOLOGE, 2014, 20 (02): : 116 - 129
  • [6] Microimaging FTIR of Head and Neck Tumors. IV
    Conti, Carla
    Ferraris, Paolo
    Garavaglia, Maria
    Giorgini, Elisabetta
    Rubini, Corrado
    Sabbatini, Simona
    Tosi, Giorgio
    MICROSCOPY RESEARCH AND TECHNIQUE, 2009, 72 (02) : 67 - 75
  • [7] Head and neck tumors Oncology update
    Dietz, Andreas
    Hoffmann, Juergen
    ONKOLOGE, 2021, 27 (09): : 929 - 935
  • [8] Second, third, and fourth head and neck tumors. A progressive decrease in survival
    Leon, Xavier
    Martinez, Vicenc
    Lopez, Montserrat
    Garcia, Jacinto
    del Prado Venegas, Maria
    Esteller, Eduard
    Quer, Miquel
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (12): : 1716 - 1719
  • [9] Pulmonary metastasectomy from head and neck tumors
    Younes, R. N.
    Fares, A. L.
    Silva Sardenberg, R. A.
    Gross, J. L.
    MINERVA CHIRURGICA, 2012, 67 (03) : 227 - 234
  • [10] Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies
    Moreira, Jonathan
    Tobias, Alexander
    O'Brien, Michael P.
    Agulnik, Mark
    DRUGS, 2017, 77 (08) : 843 - 857
12345